← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M 10b5-1 Plan

$ Value

$0

Shares

20,000

Price

$0

Filed

May 1

Insider

Name

Moat Ross

Title

CHIEF COMMERCIAL OFFICER

CIK

0001857177

Roles

Officer

Transaction Details

Transaction Date

2025-04-29

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 3, 2024. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.00 and $25.45. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $28.00 and $28.11. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | The option is fully vested and exercisable. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.

Filing Info

Accession No.

0001415889-25-011692

Form Type

4

Issuer CIK

0001730430

Moat Ross's History

Date Ticker Type Value
2026-04-09 KNSA $80K
2026-04-07 KNSA M
2026-04-07 KNSA F $38K
2026-04-07 KNSA M $0
2026-04-06 KNSA $115K
2026-04-01 KNSA M
2026-04-01 KNSA F $82K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07